Associated Papers
PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy.
Cho YA et al.
Current Oncology (toronto, Ont.), 2022
35621626 (PubMed )
Supplement: curroncol-29-00236-s001.zip › curroncol-1656685-supplementary.pdf
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
Lee HK et al.
Diagnostic Pathology, 2020
Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients.
Kaur RP et al.
Medical Oncology (northwood, London, England), 2018
PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.
Rosty C et al.
Plos One, 2013
Select a paper to view details